Company Vivos Inc.

Equities

RDGL

US92858K2042

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Medical Imaging Systems

Market Closed - OTC Markets Other stock markets 01:29:55 16/05/2024 am IST			5-day change	1st Jan Change
0.1999 ^USD	-0.47%		+18.99%	+176.49%

09/05	Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/03	Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Vivos Inc. is a radiation oncology medical device company. The Company is engaged in the development of its yttrium-90 (Y-90) based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. RadioGel is a device for human therapy for non-resectable cancers in humans. It is a hydrogel liquid containing tiny Yttrium-90 phosphate microparticles that may be administered directly into a tumor. The Companyâs IsoPet division is focused on bringing RadioGel yttrium-90 precision radionuclide therapy to veterinary oncologists to treat dogs, cats and horses suffering from cancerous tumors. The IsoPet solutions division used university veterinary hospitals to demonstrate the safety and therapeutic effectiveness for different animal cancers. The Company is also engaged in developing a micro-injection system for small tumor therapy for treating cancerous thyroid lymph nodes.

Number of employees: 1

USD in Million	2022	Weight	2023	Weight	Delta
Brachytherapy Devices 100.0 %	0	100.0 %	0	100.0 %	-46.57%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	100.0 %	0	100.0 %	-46.57%

Managers	Title	Age	Since
Michael Korenko CEO	Chief Executive Officer	77	01/16/01
Carlton Cadwell CHM	Chairman	79	01/06/01
Michael Pollack DFI	Director of Finance/CFO	57	01/18/01
Nigel Raymond Stevenson CTO	Chief Tech/Sci/R&D Officer	-	-
David J. Swanberg CTO	Chief Tech/Sci/R&D Officer	67	-
Fu-Min Su PRN	Corporate Officer/Principal	-	01/07/01
Alan R. Merkle LAW	General Counsel	-	-
Donald A. Ludwig PRN	Corporate Officer/Principal	-	-
Steven S. Honigman LAW	General Counsel	76	-

Members of the board	Title	Age	Since
Carlton Cadwell CHM	Chairman	79	01/06/01
Michael Korenko CEO	Chief Executive Officer	77	01/16/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	200,363	0	0	95.17 %
Stock B	0	2,071,007	0	0
Stock C	1	401,033,867	381,651,298 ( 95.17 %)	11,000,000 ( 2.743 %)
Stock D	0	385,302	0	0

Name	Equities	%	Valuation
Michael Korenko 2.535 %	9,885,090	2.535 %	1 M $
Carlton Cadwell 1.831 %	7,137,737	1.831 %	856 528 $
Michael Pollack 0.004104 %	16,000	0.004104 %	1 920 $

Name	Equities	%	Valuation
Carlton Cadwell 43.89 %	908,910	43.89 %	109 069 $
Leonard Jolliff 9.560 %	197,979	9.560 %	23 757 $
Stoel Rives 6.438 %	133,333	6.438 %	16 000 $
James Katzaroff 0.2636 %	5,460	0.2636 %	655 $

Name	Equities	%	Valuation
Jason Adelman 99.82 %	200,000	99.82 %	24 000 $

Name	Equities	%	Valuation
Carlton Cadwell 100.00 %	385,302	100.00 %	46 236 $

Vivos, Inc.

719 Jadwin Avenue

99352, Richland

+509-736-4000

http://www.radiogel.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Imaging Systems

	1st Jan change	Capi.
VIVOS INC.	+176.49%	78.31M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-2.78%	15.37B
IRAY TECHNOLOGY COMPANY LIMITED	-37.28%	2.92B
SONOSCAPE MEDICAL CORP.	-12.11%	2.48B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-14.23%	1.45B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+66.72%	609M
GUERBET	+90.77%	499M
DETECTION TECHNOLOGY OYJ	+18.98%	249M
DRTECH CORPORATION	-2.35%	225M

Medical Imaging Systems